A RANDOMIZED PLACEBO-CONTROLLED DOSE-FINDING STUDY OF ONABOTULINUMTOXINA IN MEN WITH BPH
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Marberger, M[Marberger, M.] | - |
dc.contributor.author | Egerdie, B[Egerdie, B.] | - |
dc.contributor.author | Chartier-Kastler, E[Chartier-Kastler, E.] | - |
dc.contributor.author | Lee, KS[Lee, K. S.] | - |
dc.contributor.author | Patel, A[Patel, A.] | - |
dc.contributor.author | Cai, J[Cai, J.] | - |
dc.contributor.author | Bugarin, D[Bugarin, D.] | - |
dc.contributor.author | Haag-Molkenteller, C[Haag-Molkenteller, C.] | - |
dc.date.accessioned | 2021-08-06T02:49:38Z | - |
dc.date.available | 2021-08-06T02:49:38Z | - |
dc.date.created | 2016-08-06 | - |
dc.date.issued | 2011-03 | - |
dc.identifier.issn | 1569-9056 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/70629 | - |
dc.title | A RANDOMIZED PLACEBO-CONTROLLED DOSE-FINDING STUDY OF ONABOTULINUMTOXINA IN MEN WITH BPH | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, KS[Lee, K. S.] | - |
dc.identifier.wosid | 000288715301258 | - |
dc.identifier.bibliographicCitation | EUROPEAN UROLOGY SUPPLEMENTS, v.10, no.2, pp.119 - 119 | - |
dc.relation.isPartOf | EUROPEAN UROLOGY SUPPLEMENTS | - |
dc.citation.title | EUROPEAN UROLOGY SUPPLEMENTS | - |
dc.citation.volume | 10 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 119 | - |
dc.citation.endPage | 119 | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.